11-64767053-T-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004630.4(SF1):c.1429A>T(p.Met477Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000511 in 1,566,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004630.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SF1 | NM_004630.4 | c.1429A>T | p.Met477Leu | missense_variant | 12/13 | ENST00000377390.8 | NP_004621.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SF1 | ENST00000377390.8 | c.1429A>T | p.Met477Leu | missense_variant | 12/13 | 1 | NM_004630.4 | ENSP00000366607 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151976Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000228 AC: 5AN: 219110Hom.: 0 AF XY: 0.0000254 AC XY: 3AN XY: 118332
GnomAD4 exome AF: 0.00000495 AC: 7AN: 1414522Hom.: 0 Cov.: 35 AF XY: 0.00000429 AC XY: 3AN XY: 698548
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151976Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74218
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2024 | The c.1804A>T (p.M602L) alteration is located in exon 12 (coding exon 12) of the SF1 gene. This alteration results from a A to T substitution at nucleotide position 1804, causing the methionine (M) at amino acid position 602 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at